Ilex Medical Ltd (ILX.TA)
ILA 6322.0
(0.51%)
ILA 6322.0
(0.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 50.88 Million ILS | -50.17% |
| 2022 | 102.12 Million ILS | -48.29% |
| 2021 | 197.48 Million ILS | 63.72% |
| 2020 | 120.62 Million ILS | 100.18% |
| 2019 | 60.25 Million ILS | 28.26% |
| 2018 | 46.98 Million ILS | 25.61% |
| 2017 | 37.4 Million ILS | 35.27% |
| 2016 | 27.65 Million ILS | -11.11% |
| 2015 | 31.1 Million ILS | 40.73% |
| 2014 | 22.1 Million ILS | 199.51% |
| 2013 | -22.21 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 13.92 Million ILS | -37.97% |
| 2024 Q2 | 5.48 Million ILS | -60.59% |
| 2023 Q3 | 8.89 Million ILS | -16.4% |
| 2023 Q4 | 22.44 Million ILS | 152.47% |
| 2023 FY | 50.88 Million ILS | -50.17% |
| 2023 Q1 | 8.91 Million ILS | -76.65% |
| 2023 Q2 | 10.63 Million ILS | 19.27% |
| 2022 FY | 102.12 Million ILS | -48.29% |
| 2022 Q4 | 38.18 Million ILS | 99.37% |
| 2022 Q3 | 19.15 Million ILS | 32366.1% |
| 2022 Q2 | 59 Thousand ILS | -99.87% |
| 2022 Q1 | 44.72 Million ILS | 4.13% |
| 2021 Q2 | 31.13 Million ILS | -21.1% |
| 2021 Q4 | 42.94 Million ILS | -48.84% |
| 2021 Q3 | 83.94 Million ILS | 169.62% |
| 2021 Q1 | 39.46 Million ILS | 30.71% |
| 2021 FY | 197.48 Million ILS | 63.72% |
| 2020 Q3 | 49.63 Million ILS | 87.89% |
| 2020 Q1 | 14.37 Million ILS | 30.9% |
| 2020 Q2 | 26.41 Million ILS | 83.74% |
| 2020 Q4 | 30.18 Million ILS | -39.18% |
| 2020 FY | 120.62 Million ILS | 100.18% |
| 2019 Q4 | 10.98 Million ILS | -41.96% |
| 2019 FY | 60.25 Million ILS | 28.26% |
| 2019 Q2 | 16.37 Million ILS | 17.17% |
| 2019 Q1 | 13.97 Million ILS | -2.77% |
| 2019 Q3 | 18.92 Million ILS | 15.59% |
| 2018 Q3 | 12.68 Million ILS | 3.86% |
| 2018 Q1 | 7.7 Million ILS | 14.9% |
| 2018 Q2 | 12.21 Million ILS | 58.6% |
| 2018 FY | 46.98 Million ILS | 25.61% |
| 2018 Q4 | 14.37 Million ILS | 13.26% |
| 2017 Q3 | 9.7 Million ILS | 2.17% |
| 2017 Q4 | 6.7 Million ILS | -30.9% |
| 2017 FY | 37.4 Million ILS | 35.27% |
| 2017 Q1 | 11.5 Million ILS | 99.7% |
| 2017 Q2 | 9.49 Million ILS | -17.43% |
| 2016 Q2 | 6.29 Million ILS | -8.12% |
| 2016 Q3 | 8.74 Million ILS | 39.03% |
| 2016 Q1 | 6.84 Million ILS | 47.45% |
| 2016 Q4 | 5.75 Million ILS | -34.18% |
| 2016 FY | 27.65 Million ILS | -11.11% |
| 2015 Q2 | 8.48 Million ILS | -23.5% |
| 2015 Q1 | 11.09 Million ILS | 443.96% |
| 2015 FY | 31.1 Million ILS | 40.73% |
| 2015 Q4 | 4.64 Million ILS | -32.45% |
| 2015 Q3 | 6.87 Million ILS | -18.99% |
| 2014 FY | 22.1 Million ILS | 199.51% |
| 2014 Q4 | -3.22 Million ILS | -120.15% |
| 2014 Q3 | 16.01 Million ILS | 155.09% |
| 2014 Q2 | 6.27 Million ILS | 106.48% |
| 2014 Q1 | 3.04 Million ILS | 108.18% |
| 2013 Q2 | 4.64 Million ILS | -32.31% |
| 2013 Q4 | -37.15 Million ILS | -1181.46% |
| 2013 FY | -22.21 Million ILS | 0.0% |
| 2013 Q3 | 3.43 Million ILS | -26.06% |
| 2013 Q1 | 6.86 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|